Diphenhydramine HCl 50 mg Capsules Recalled Due to Incorrect ID Imprinting
Akron Pharma is recalling 324 bottles of Diphenhydramine HCl 50 mg capsules (lot KDC0224001B) due to incorrect identification imprinting on the capsules. The product was distributed nationwide in the United States.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: FDA Class III recall for incorrect ID imprinting on capsules, classified as a labeling/documentation issue without reported illnesses or injuries. Per the severity rubric, documentation issues are classified as Level 1 (Low).
Plain-English summary
Akron Pharma, Inc. is recalling Diphenhydramine HCl 50 mg capsules because the capsules are imprinted with an incorrect identification code. This is an FDA Class III recall.
The recall affects 324 bottles, each containing 1,000 capsules, bearing lot number KDC0224001B with an expiration date of September 30, 2026. The recalled product was distributed nationwide in the United States.
The product is manufactured by Akron Pharma, Inc., located at 373 Route US 46, Building E, Suite 117, Fairfield, NJ 07004, with National Drug Code (NDC) 71399-8026-02.
The recalled product
- Product
- Diphenhydramine HCl 50 mg, 1000 capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc. 373 Route US 46, Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8026-02.
- Manufacturer
- Akron Pharma, Inc.
- Category
- Drug
- Affected units
- 324
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: KDC0224001B Exp 09/30/2026
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 7 recalled by Akron Pharma, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same manufacturer · Akron Pharma, Inc.
See all →- LowAcetaminophen tablets recalled for incorrect imprinting
FDA (Drugs) · 2025-01-22
- ModerateAcetaminophen 325 mg tablets recalled for incorrect imprinting
FDA (Drugs) · 2025-01-22
- LowDiphenhydramine HCl Capsules Recalled Due to Wrong ID Imprinting
FDA (Drugs) · 2025-01-22
- ModerateAcetaminophen Extra Strength tablets recalled for incorrect product imprint identification
FDA (Drugs) · 2025-01-22
- ModerateDiphenhydramine HCl Capsules Recalled Due to Wrong Imprinting
FDA (Drugs) · 2025-01-22